Bladder stones in dogs and pet insurance: four stone types, three clause designs, and the second surgery

Four stones, four different bills

The ACVIM statement (Lulich and colleagues, Journal of Veterinary Internal Medicine, 2016) was built by having six specialists vote on common clinical scenarios and then reach a consensus. Its first recommendation sets the tone for insurance as well as medicine. Struvite stones, in dogs usually the product of a urinary infection with urease-producing bacteria and alkaline urine, "should be medically dissolved" unless drugs or dissolution foods cannot be given, the stone cannot be bathed in modified urine, or infection cannot be controlled. A dissolution is a course of antibiotics, a prescribed diet, cultures and imaging. There is no operating room on the invoice. The panel adds that dissolution avoids anesthesia and surgery and "in many cases" costs less than surgery.

Calcium oxalate is the opposite case. The statement says calcium oxalate stones "are not amenable to medical dissolution", so a symptomatic calcium oxalate stone is a removal case. For removal the panel prefers minimally invasive methods (voiding urohydropropulsion, basket retrieval, laser lithotripsy or percutaneous cystolithotomy) over open cystotomy, citing shorter hospitalization and anesthesia, fewer residual stones, and the fact that sutured bladders can themselves seed new stones, which it puts at about 9 percent of recurrent stones in the cited work. It also says the urethras of small male dogs such as Yorkshire Terriers, Maltese and Chihuahuas may be too narrow for the cystoscopes these procedures need, so for a stone in the urethra of those dogs the statement describes pushing it back into the bladder and removing it by percutaneous cystolithotomy or cystotomy; the breeds are covered on the Yorkshire Terrier and Chihuahua pages. The panel set cost aside on purpose: it recognized that cost and willingness to travel affect choices, but did not include them in its standard of care.

Urate and cystine stones sit between the two. Urate stones are driven by excess uric acid in the urine; the statement names a mutation in a uric acid transporter gene (SLC2A9) in Dalmatians and Bulldogs, and portovascular anomalies in Yorkshire Terriers and Pugs, as common causes, while noting that for some animals the cause stays unknown. Cystine stones come from cystinuria, which the panel calls a rare genetic disease. For both, the panel says dissolution may be attempted before removal, with a purine-restricted alkalinizing diet and allopurinol for urate and a low-protein, alkalinizing diet with tiopronin for cystine. In the one dog study it cites for urate, dissolution worked in about 40 percent of Dalmatians, partly in 30 percent and not at all in 30 percent.

Only one row of that table ends in an operating room as a matter of course. The phrase "bladder stone surgery" in a search fits calcium oxalate cleanly, and the small dogs that cannot take a scope. The other three begin with a diet, a drug and a urine culture, which an insurer files under different headings from surgery. The prescription food guide compares what six forms say about the diet line on its own.

What the recurrence evidence is, and why the model below runs scenarios

None of the sources cited here gives a probability that a dog will form a second stone, by type. The ACVIM statement lists calcium oxalate, cystine and urate among urolith types that are "highly recurrent", and for calcium oxalate it says outright that properly designed clinical trials evaluating recurrence have not been published. The numbers it does contain are narrow. One is the share of recurrent stones that a suture may have started, about 9 percent, which describes the causes of recurrences and says nothing about how often they occur. The other comes from a crossover study of six Dalmatians with urate stones: after six months, 50 percent of the dogs eating a low-purine, low-protein food had recurrent stones against 87 percent on a maintenance food, and every recurrent stone was under 2 millimeters, with no clinical signs. Six dogs on a 1997 abstract is not a forecast for anyone's dog.

The Texas A&M interventional radiology and endoscopy service, in its 2024 information sheets on laser lithotripsy and percutaneous cystolithotomy, says only that stone recurrence "is likely without appropriate long-term management". That is the strongest sentence in the sources, and it is qualitative.

So the model below does not weight outcomes. It prices three paths, with the same stone returning zero times, once a year later, and twice in successive policy years, for each stone type and each clause design. A reader can find the path that matches their dog's history, and a veterinarian is the one who can say how likely it is. Because the invoices are the same in every year, the model also holds prices flat; real bills move.

One stone, zero, one or two returns, under three designs

Three designs cover how these forms handle the money. Design A is the annual reset pattern: the deductible and the annual limit start again at every renewal. The Spot Arizona sample says the deductible "applies during each policy period", AKC's North Carolina sample defines it as an annual amount, Figo's multi-state sample calls it the Policy Annual Deductible, and Pets Best's 12/2015 booklet says limits and deductibles "reset" after each renewal date (its newer Arizona sample, IAIC-PB10001-ILL, uses the same word). The inputs are a $500 deductible, 80 percent reimbursement, a $10,000 annual limit and exam fees covered.

Design B is the per-condition pattern of Trupanion's policy form TRU-00001, dated 08/11: no limits on any claim or year, a deductible "for any one condition or injury", and veterinary examination fees excluded. The form puts the co-insurance rate on the declarations page, so 80 percent is an assumption, with the same $500 deductible. Design C is the schedule pattern of Nationwide's Superior Plan form VS-21, dated 02-17: it pays "90% of covered veterinary services expenses up to a maximum of 90% of the Benefit Schedule diagnostic code", less the deductible, with the deductible applied "once to each incident". The schedule printed with the sample says "Effective 4-07", so this is an old design; its deductible is also on a declarations page, and $250 is assumed here. The schedule lists urolithiasis-surgical (code 1801) at $668 in the primary column, $173 for diagnostic testing and $110 for anesthesia, which stack to $951 for a stone surgery if the three columns are read as additive, as their descriptions suggest. Ninety percent of $951 is $855.90, and less the $250 deductible the form pays $605.90 per incident.

Designs B and C each have two readings, because the form has to decide whether the returning stone is the same thing as the first.

Design B eligible amount is $3,425 because the $175 of exam fees is excluded (3,600 minus 175). Design C cap is 0.9 x (668 + 173 + 110) = $855.90, less a $250 deductible; the last row assumes every return falls in the same policy term as the first stone, which the wording of the form ties to one incident. Annual limit in Design A ($10,000) is not reached. Amounts are before any co-payment the declarations page may add.

The gap between B's two readings is $400, which is one deductible at 80 percent: $500 x 0.8. Nothing else in the form differs between the readings, so the question of whether a returning stone is the same condition is worth $400 on that form, per return: one deductible at 80 percent. On Design A the joining rule moves no money on the deductible at all, because it restarts every year, so the joining question matters there for other reasons: whether the new stone is excluded as a chronic or pre-existing condition. Timing inside the year does matter. Two removals in one policy year cost the owner one deductible, not two: (7,200 minus 500) x 0.8 = $5,360, against $4,960 for two removals a renewal apart. A $5,000 annual limit would cap that same-year claim at $5,000 instead of $5,360.

Design C is a different kind of contract. One surgery returns $605.90 of $3,600, or 16.8 percent, because the schedule caps the benefit well below the bill. If all three removals fall in one policy term and the stone is one ongoing incident, the owner keeps $10,194.10 of $10,800, or 94.4 percent. The form pays expenses "you incur during the policy term" and applies the deductible "once to each incident during the policy term"; it does not say whether an ongoing incident carries into the next term, so the table shows only the same-term fold-in and treats a return after a renewal as a new incident. This design is a 2007 schedule inside a 2017 form: current Nationwide products are not described here.

The same dissolution returning: what each reading adds

Infection-induced struvite recurs when the infection does, and the panel's primary prevention is to find and clear the infection. So the plausible second and third paths are repeat dissolutions after a new urinary infection. The table runs those through the same designs.

Owner share equals billed ($1,345, $2,690, $4,035) minus the insurer payment shown.

At this size the deductible takes more than a third of the first episode on Designs A and B, and the schedule design pays almost nothing, since its medical allowance sits barely above its deductible. The point of the pair of tables is the difference in shape. A calcium oxalate dog meets the question of whether returns are one condition at the surgical scale, where a fold-in can cost thousands. A struvite dog meets it at a few hundred dollars, and meets the food clauses instead. Because a stone that was dissolved can be followed by a prevention diet, the diet-as-treatment-or-maintenance section of the prescription food guide is where the next year's money is decided.

Is the second stone surgery the same condition? Seven forms, in their own words

The joining question gets a different answer in each form, and in some it is not answered at all. These are the sentences that bear on it, quoted from the filed or sample text and dated by edition. Where a form is old the table says so: a filed form dated 2011, 2015 or 2017 is a record of what that edition said, not the terms of a current policy. Pets Best posts two generations of sample at once, the 12/2015 booklet for some states and IAIC-PB10001-ILL for others, and the rows say which wording belongs to which.

Reading the clinical statement next to the contracts produces two collisions. The first is the word "cured" in the Nationwide Superior Plan form: it means "resolution of a condition so that ongoing or intermittent treatment is not required and recurrences or complications are not expected." The ACVIM statement calls three of the four stone types highly recurrent, and says the high recurrence rate warrants a comprehensive approach and regular monitoring. On its words, the form's definition of a cured stone turns on an expectation that the clinical literature does not support for those types. Whether any insurer applies it that way to a particular dog is not written in the form, which is the reason to ask in writing before the second surgery rather than after it.

The second is the Nationwide Major Medical form's treatment of time. Because it caps each allowance per policy term "regardless of the number of incidents", a second removal in the same term adds nothing to that diagnosis, and the same removal one renewal later adds a fresh allowance. The date of the second stone relative to the policy's renewal can matter more than anything about the stone. That form's schedule lists urolithiasis-medical (1809) at $385 primary and $150 secondary and a bladder procedure (1801, "Acquired Bladder Disorder-Surgical") at $1,565 in the secondary column; the form does not say which code a stone removal is filed under, so no payment is computed from it here. The deductible, reimbursement and limits guide charts annual against per-condition deductibles over several years, and the stomach and pancreas guide shows the same joining language at work on a different recurring illness. Other illnesses that return, from Cushing's disease to epilepsy, are collected in the conditions guides.

A stone already in the record: cured, chronic, or kept quiet by a diet

A dog that had a stone before the policy meets the pre-existing clause, and the forms offer four different routes back. Figo's sample defines a pre-existing illness as one that first occurred or showed clinical signs in the twelve months before the original start date, and then adds: "If Your Pet's Pre-existing Condition is curable and has been Cured and free from Treatment and symptoms for a period of twelve (12) months, that condition will no longer be subject to the Pre-existing Condition provision." The same definition lists a chronic condition observed before the start date as pre-existing, and the cured route applies to a condition that is "curable"; Figo defines chronic as incurable or likely to last for the pet's life. Spot's sample has the same shape with a 180-day clock and a sentence that the rule "does not apply to chronic conditions".

AKC's North Carolina sample takes another path. It treats any illness that "occurred, reoccurred, existed or showed Symptoms" before the start date as pre-existing, but says such conditions "are only eligible after three hundred and sixty-five (365) days of continuous coverage and only for Treatment that occurs after" that period. There is no cured test to pass, only the wait. The Nationwide Superior Plan form says a condition "is not pre-existing if it was cured before the effective date of this insurance policy and there has not been a recurrence or manifestation of the condition for at least six (6) months", with the cured definition quoted in the last section. The 2015 Nationwide Major Medical form, Trupanion's 08/11 policy and Pets Best's 12/2015 booklet have no cured exception in the exclusion text: the first excludes "any preexisting condition", the second looks back 18 months for "evidence and/or symptoms of their potential manifestation", and the third looks back 18 months, deems chronic conditions pre-existing if they were present, and counts conditions "in remission or controlled by medication" as present. The newer Pets Best sample (IAIC-PB10001-ILL, Arizona, no edition date printed) drops the 18-month look-back and the deemed-chronic rule: it asks whether advice, treatment or signs "directly related" to the condition came before the effective date or during a waiting period, still counts conditions "in remission or controlled by medication" as present, offers no cured route, and says a condition covered on a policy "cannot be considered a Pre-existing Condition on any renewal of the policy."

Then there is the clock. The cured routes at Figo and Spot require the pet to be free from treatment as well as symptoms. Figo defines Treatment as "any examination, consultation, hospitalization, anesthesia, Surgery, X-rays, MRI or CT scans, laboratory tests, nursing, or other care provided and administered by a Veterinary Provider". The ACVIM panel recommends cultures, urine concentration checks and imaging after a stone. On the form's words, those monitoring visits are laboratory tests and examinations, and a lifelong prevention diet is a candidate for "other care". Whether a monitored dog with no stone for twelve months is "free from Treatment" is therefore a question the sample does not answer, and it is the one an owner with a previous stone should put to the insurer. Trupanion's 08/11 form adds a different risk: it excludes "abnormalities" present in the 18 months before enrollment, including those "noted from diagnostic testing, screening or radiographs", and a stone seen on a radiograph taken for another reason can be that note. The pre-existing conditions guide compares the definitions across more forms, and the waiting periods guide covers the illness clocks that run before cover starts. The collapsing trachea guide tests the same routes back against a lifelong disease.

Urate and cystine: where the exclusions are written

The two inherited stone types are where the forms diverge most, and the Nationwide forms are the only ones of the seven that name a stone. The Superior Plan form's exclusion E lists "The following urinary tract disorders: (1) renal dysplasia, and (2) cystine urolithiasis", with no first-year condition attached. Its exclusion J, on congenital disorders, gives "urinary tract calculi secondary to metabolic defects" as an example, and exclusion K removes hereditary disorders; a urate stone caused by an inherited transporter defect is a plausible fit for either. The 2015 Major Medical form uses a list instead. Its ineligible-conditions pages name cystine, urate and xanthine urolithiasis in the bladder and the urethra, medical and surgical, and Section 7 pays at most $275 for diagnosis or medical treatment of the whole list and $550 for surgery per policy term, with nothing at all in the first twelve months. The first-year condition sits in the 2015 form's Section 7; the 2017 form's exclusion E carries no such condition.

Other forms exclude by category, not by name. AKC's exclusion y removes "Congenital and Inherited conditions" (listing hip dysplasia, luxating patella and diabetes among others) unless the optional HereditaryPlus coverage is bought, and defines Inherited as a condition "whose presence is determined by genetic factors". The Figo sample lists "Genetic Conditions" among covered illnesses, with an "(if shown as applicable on the Declarations Page(s))" qualifier. The Trupanion 08/11 form has no general hereditary exclusion, only an optional hip dysplasia benefit, and the Pets Best samples (12/2015 and Arizona) and the Spot Arizona sample have none in the text. Whether a given stone falls into one of these categories depends on what the record says. A stone analysis report that names urate establishes the mineral, not the cause, and the panel says the cause is unknown in some animals. A DNA result or a diagnosis of a portosystemic shunt would establish it. The hereditary and bilateral exclusions guide sets out how these clauses are tested, and the English Bulldog and Pug pages are where two of the breeds the panel names are covered.

For the model, this means the urate or cystine dog's path is binary on many forms. Under Design A with nothing excluded, the first removal repays $2,480 as above; under the Superior Plan wording or AKC without the rider it can be $0. There is no sensible midpoint to average, which is another reason not to average them.

Prevention diets, citrate and the duty to prevent a recurrence

After a stone, the panel's prevention advice is mostly food, water and drugs: high-moisture food, a urine specific gravity at or below 1.020 in dogs for calcium oxalate, avoiding urine acidification, potassium citrate in some dogs, and for urate and cystine stones, protein or purine limits and, sometimes, allopurinol or tiopronin. The forms split on every one of those items. The Nationwide Superior Plan excludes "Special diets, pet foods, vitamins, minerals and nutritional supplements" (exclusion O) and the 2015 form does so "even if prescribed by a veterinarian". Figo excludes "all foods, whether prescribed or not", with an exam-fee rider that adds back food prescribed "as the sole Treatment for an Illness" up to $250 a policy term. AKC excludes "All diets, Pet food, whether prescribed or not", except "a prescription diet used as the sole Treatment of a covered condition". Spot pays prescription food "to treat a covered condition" and excludes food "used beyond resolution of symptoms for prevention". Trupanion's 08/11 form pays the incremental cost of therapeutic food, defined as 50 percent of its price, for up to two months. The Pets Best sample excludes pet foods and supplements, and covers take-home prescription drugs only as a supplemental benefit, limited to a formulary.

Read together, a dissolution diet fed while a stone is being treated has a plausible home on Spot's and Trupanion's wording, and none on the two Nationwide forms. The day the stone is gone, the same bag becomes prevention, which Spot's exclusion t removes in terms. The panel's prevention recommendations carry no end date in the text. So a dog whose stone type needs a lifelong diet is, on most of these forms, paying for it outside the policy, which is why the model above excludes food from Design A.

The same advice appears on the other side of the contract as a duty. The Nationwide Superior Plan says "You must reasonably protect your pet from aggravation of any condition". Trupanion's 08/11 form asks the owner "to protect the pet from aggravation and/or recurrence of the injury and/or illness after occurrence". Pets Best's booklet repeats that duty, and its exclusion C.11 removes "Any Accident, Condition, or Cruciate Ligament Event with respect to which the Policyholder was advised by a Veterinarian to take preventive measures, and did not meet the terms" (item 6.f of the newer Arizona sample words it the same way). Figo's Part II asks the owner to protect the pet from "aggravation or recurrence of any Injury or Illness after its initial occurrence". None of these clauses names a stone, a diet or a recheck. But a veterinarian who has put moisture, a diet and a culture schedule in the record has written the standard the clause would be measured against, and a second stone after a missed recheck is a plausible test case. This site does not know how claims on these clauses are decided; the practical step is to keep the dated advice and the dated purchases together.

Where a returning stone stands, by what the record shows

Seven situations an owner can check against the policy and the medical record. Each reflects the sample wording above; the policy in hand and its declarations page govern.

Written answers worth having before a second stone is removed

• Does the policy treat a stone that returns after treatment as the same condition or a new one, for the deductible, the per-incident limit and the pre-existing clause?
• Is a bladder stone of the type on the analysis report, urate or cystine especially, reached by a hereditary, congenital or ineligible-condition clause on the declarations page and the form?
• Does a prescription urinary diet, potassium citrate or a stone-prevention drug count as covered care while a stone is being treated, and when does it become prevention?
• Do routine urine cultures, specific gravity checks and imaging after a stone count as treatment for any cured-condition clock?
• If the first stone predates the policy, which route back applies: a cured clock, a 365-day wait, or none?
• Where does the renewal date fall against the date of a likely second removal, and what is paid if two removals land in one policy year?